nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemfibrozil—CYP1A2—Imiquimod—skin cancer	0.117	0.147	CbGbCtD
Gemfibrozil—CYP2C8—Vismodegib—skin cancer	0.105	0.131	CbGbCtD
Gemfibrozil—CYP2C19—Vismodegib—skin cancer	0.0877	0.11	CbGbCtD
Gemfibrozil—CYP2C9—Vismodegib—skin cancer	0.0729	0.0916	CbGbCtD
Gemfibrozil—CYP1A2—Vemurafenib—skin cancer	0.064	0.0803	CbGbCtD
Gemfibrozil—CYP3A4—Temozolomide—skin cancer	0.0612	0.0768	CbGbCtD
Gemfibrozil—CYP3A4—Imiquimod—skin cancer	0.0612	0.0768	CbGbCtD
Gemfibrozil—CYP1A2—Dacarbazine—skin cancer	0.049	0.0616	CbGbCtD
Gemfibrozil—CYP3A4—Vismodegib—skin cancer	0.0424	0.0532	CbGbCtD
Gemfibrozil—CYP2C8—Fluorouracil—skin cancer	0.0371	0.0466	CbGbCtD
Gemfibrozil—CYP3A4—Vemurafenib—skin cancer	0.0335	0.0421	CbGbCtD
Gemfibrozil—CYP1A2—Fluorouracil—skin cancer	0.0288	0.0361	CbGbCtD
Gemfibrozil—CYP2C9—Fluorouracil—skin cancer	0.0259	0.0325	CbGbCtD
Gemfibrozil—CYP3A4—Docetaxel—skin cancer	0.0115	0.0144	CbGbCtD
Gemfibrozil—Arthralgia—Vemurafenib—skin cancer	0.000758	0.00379	CcSEcCtD
Gemfibrozil—Myalgia—Vemurafenib—skin cancer	0.000758	0.00379	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.000752	0.00376	CcSEcCtD
Gemfibrozil—Vomiting—Vismodegib—skin cancer	0.000748	0.00374	CcSEcCtD
Gemfibrozil—Drug interaction—Docetaxel—skin cancer	0.000746	0.00373	CcSEcCtD
Gemfibrozil—Rash—Vismodegib—skin cancer	0.000741	0.00371	CcSEcCtD
Gemfibrozil—Dermatitis—Vismodegib—skin cancer	0.000741	0.0037	CcSEcCtD
Gemfibrozil—Pancytopenia—Bleomycin—skin cancer	0.000735	0.00367	CcSEcCtD
Gemfibrozil—Blood bilirubin increased—Docetaxel—skin cancer	0.000732	0.00366	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Vemurafenib—skin cancer	0.000726	0.00363	CcSEcCtD
Gemfibrozil—Nervous system disorder—Vemurafenib—skin cancer	0.000712	0.00356	CcSEcCtD
Gemfibrozil—Skin disorder—Vemurafenib—skin cancer	0.000706	0.00353	CcSEcCtD
Gemfibrozil—Weight decreased—Bleomycin—skin cancer	0.0007	0.0035	CcSEcCtD
Gemfibrozil—Nausea—Vismodegib—skin cancer	0.000698	0.00349	CcSEcCtD
Gemfibrozil—Angioedema—Imiquimod—skin cancer	0.000694	0.00347	CcSEcCtD
Gemfibrozil—Phosphatase alkaline increased—Docetaxel—skin cancer	0.000692	0.00346	CcSEcCtD
Gemfibrozil—Pancytopenia—Dactinomycin—skin cancer	0.000685	0.00343	CcSEcCtD
Gemfibrozil—Breast disorder—Temozolomide—skin cancer	0.000683	0.00341	CcSEcCtD
Gemfibrozil—Syncope—Imiquimod—skin cancer	0.000681	0.0034	CcSEcCtD
Gemfibrozil—Loss of consciousness—Imiquimod—skin cancer	0.000667	0.00334	CcSEcCtD
Gemfibrozil—Muscular weakness—Temozolomide—skin cancer	0.000666	0.00333	CcSEcCtD
Gemfibrozil—Colitis—Docetaxel—skin cancer	0.000664	0.00332	CcSEcCtD
Gemfibrozil—Cough—Imiquimod—skin cancer	0.000662	0.00331	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000662	0.00331	CcSEcCtD
Gemfibrozil—Convulsion—Imiquimod—skin cancer	0.000658	0.00329	CcSEcCtD
Gemfibrozil—PPARA—blood vessel—skin cancer	0.000647	0.191	CbGeAlD
Gemfibrozil—Myalgia—Imiquimod—skin cancer	0.000646	0.00323	CcSEcCtD
Gemfibrozil—Arthralgia—Imiquimod—skin cancer	0.000646	0.00323	CcSEcCtD
Gemfibrozil—Chest pain—Imiquimod—skin cancer	0.000646	0.00323	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.000642	0.00321	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000627	0.00314	CcSEcCtD
Gemfibrozil—Fatigue—Vemurafenib—skin cancer	0.000626	0.00313	CcSEcCtD
Gemfibrozil—Nasopharyngitis—Fluorouracil—skin cancer	0.000622	0.00311	CcSEcCtD
Gemfibrozil—Constipation—Vemurafenib—skin cancer	0.000621	0.00311	CcSEcCtD
Gemfibrozil—Pancytopenia—Temozolomide—skin cancer	0.00062	0.0031	CcSEcCtD
Gemfibrozil—Oedema—Imiquimod—skin cancer	0.000619	0.0031	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Bleomycin—skin cancer	0.000616	0.00308	CcSEcCtD
Gemfibrozil—Muscular weakness—Fluorouracil—skin cancer	0.000614	0.00307	CcSEcCtD
Gemfibrozil—Shock—Imiquimod—skin cancer	0.000609	0.00305	CcSEcCtD
Gemfibrozil—Nervous system disorder—Imiquimod—skin cancer	0.000607	0.00304	CcSEcCtD
Gemfibrozil—Skin disorder—Imiquimod—skin cancer	0.000602	0.00301	CcSEcCtD
Gemfibrozil—Erectile dysfunction—Temozolomide—skin cancer	0.000601	0.00301	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Temozolomide—skin cancer	0.000596	0.00298	CcSEcCtD
Gemfibrozil—Eosinophilia—Fluorouracil—skin cancer	0.000596	0.00298	CcSEcCtD
Gemfibrozil—Weight decreased—Temozolomide—skin cancer	0.000591	0.00295	CcSEcCtD
Gemfibrozil—Depression—Temozolomide—skin cancer	0.00058	0.0029	CcSEcCtD
Gemfibrozil—Blood alkaline phosphatase increased—Docetaxel—skin cancer	0.000577	0.00289	CcSEcCtD
Gemfibrozil—Pancytopenia—Fluorouracil—skin cancer	0.000571	0.00286	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Temozolomide—skin cancer	0.000571	0.00285	CcSEcCtD
Gemfibrozil—Urinary tract infection—Temozolomide—skin cancer	0.000566	0.00283	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000564	0.00282	CcSEcCtD
Gemfibrozil—Paraesthesia—Imiquimod—skin cancer	0.000556	0.00278	CcSEcCtD
Gemfibrozil—Somnolence—Imiquimod—skin cancer	0.000551	0.00275	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Temozolomide—skin cancer	0.00055	0.00275	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Fluorouracil—skin cancer	0.000549	0.00274	CcSEcCtD
Gemfibrozil—Alopecia—Bleomycin—skin cancer	0.000547	0.00274	CcSEcCtD
Gemfibrozil—Dyspepsia—Imiquimod—skin cancer	0.000545	0.00273	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Imiquimod—skin cancer	0.000535	0.00267	CcSEcCtD
Gemfibrozil—Fatigue—Imiquimod—skin cancer	0.000534	0.00267	CcSEcCtD
Gemfibrozil—Atrial fibrillation—Docetaxel—skin cancer	0.00053	0.00265	CcSEcCtD
Gemfibrozil—Pain—Imiquimod—skin cancer	0.00053	0.00265	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Fluorouracil—skin cancer	0.000526	0.00263	CcSEcCtD
Gemfibrozil—Urinary tract infection—Fluorouracil—skin cancer	0.000521	0.00261	CcSEcCtD
Gemfibrozil—Asthenia—Vemurafenib—skin cancer	0.000521	0.00261	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Temozolomide—skin cancer	0.00052	0.0026	CcSEcCtD
Gemfibrozil—Pruritus—Vemurafenib—skin cancer	0.000514	0.00257	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Temozolomide—skin cancer	0.000513	0.00257	CcSEcCtD
Gemfibrozil—Alopecia—Dactinomycin—skin cancer	0.00051	0.00255	CcSEcCtD
Gemfibrozil—Feeling abnormal—Imiquimod—skin cancer	0.00051	0.00255	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Imiquimod—skin cancer	0.000507	0.00253	CcSEcCtD
Gemfibrozil—Anaemia—Bleomycin—skin cancer	0.000498	0.00249	CcSEcCtD
Gemfibrozil—Diarrhoea—Vemurafenib—skin cancer	0.000497	0.00248	CcSEcCtD
Gemfibrozil—Urticaria—Imiquimod—skin cancer	0.000492	0.00246	CcSEcCtD
Gemfibrozil—Abdominal pain—Imiquimod—skin cancer	0.00049	0.00245	CcSEcCtD
Gemfibrozil—Eye disorder—Temozolomide—skin cancer	0.000488	0.00244	CcSEcCtD
Gemfibrozil—Leukopenia—Bleomycin—skin cancer	0.000483	0.00241	CcSEcCtD
Gemfibrozil—Rhinitis—Fluorouracil—skin cancer	0.000483	0.00241	CcSEcCtD
Gemfibrozil—Dizziness—Vemurafenib—skin cancer	0.00048	0.0024	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Fluorouracil—skin cancer	0.000479	0.0024	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Temozolomide—skin cancer	0.000471	0.00235	CcSEcCtD
Gemfibrozil—Cough—Bleomycin—skin cancer	0.000471	0.00235	CcSEcCtD
Gemfibrozil—Anaemia—Dactinomycin—skin cancer	0.000465	0.00232	CcSEcCtD
Gemfibrozil—Liver function test abnormal—Docetaxel—skin cancer	0.000464	0.00232	CcSEcCtD
Gemfibrozil—PPARA—neck—skin cancer	0.000463	0.136	CbGeAlD
Gemfibrozil—Vomiting—Vemurafenib—skin cancer	0.000462	0.00231	CcSEcCtD
Gemfibrozil—Alopecia—Temozolomide—skin cancer	0.000462	0.00231	CcSEcCtD
Gemfibrozil—Chest pain—Bleomycin—skin cancer	0.000459	0.0023	CcSEcCtD
Gemfibrozil—Myalgia—Bleomycin—skin cancer	0.000459	0.0023	CcSEcCtD
Gemfibrozil—Abdominal pain upper—Docetaxel—skin cancer	0.000459	0.00229	CcSEcCtD
Gemfibrozil—Rash—Vemurafenib—skin cancer	0.000458	0.00229	CcSEcCtD
Gemfibrozil—Mental disorder—Temozolomide—skin cancer	0.000458	0.00229	CcSEcCtD
Gemfibrozil—Dermatitis—Vemurafenib—skin cancer	0.000458	0.00229	CcSEcCtD
Gemfibrozil—Headache—Vemurafenib—skin cancer	0.000455	0.00228	CcSEcCtD
Gemfibrozil—Breast disorder—Docetaxel—skin cancer	0.000454	0.00227	CcSEcCtD
Gemfibrozil—Leukopenia—Dactinomycin—skin cancer	0.00045	0.00225	CcSEcCtD
Gemfibrozil—Nasopharyngitis—Docetaxel—skin cancer	0.000449	0.00225	CcSEcCtD
Gemfibrozil—Dysgeusia—Temozolomide—skin cancer	0.000445	0.00223	CcSEcCtD
Gemfibrozil—Asthenia—Imiquimod—skin cancer	0.000444	0.00222	CcSEcCtD
Gemfibrozil—Confusional state—Bleomycin—skin cancer	0.000444	0.00222	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Bleomycin—skin cancer	0.00044	0.0022	CcSEcCtD
Gemfibrozil—Oedema—Bleomycin—skin cancer	0.00044	0.0022	CcSEcCtD
Gemfibrozil—Pruritus—Imiquimod—skin cancer	0.000438	0.00219	CcSEcCtD
Gemfibrozil—Nausea—Vemurafenib—skin cancer	0.000431	0.00216	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Bleomycin—skin cancer	0.000431	0.00215	CcSEcCtD
Gemfibrozil—Vision blurred—Temozolomide—skin cancer	0.000429	0.00214	CcSEcCtD
Gemfibrozil—Myalgia—Dactinomycin—skin cancer	0.000428	0.00214	CcSEcCtD
Gemfibrozil—Alopecia—Fluorouracil—skin cancer	0.000425	0.00213	CcSEcCtD
Gemfibrozil—Diarrhoea—Imiquimod—skin cancer	0.000424	0.00212	CcSEcCtD
Gemfibrozil—Anaemia—Temozolomide—skin cancer	0.00042	0.0021	CcSEcCtD
Gemfibrozil—Angioedema—Temozolomide—skin cancer	0.000416	0.00208	CcSEcCtD
Gemfibrozil—Pancytopenia—Docetaxel—skin cancer	0.000412	0.00206	CcSEcCtD
Gemfibrozil—Oedema—Dactinomycin—skin cancer	0.00041	0.00205	CcSEcCtD
Gemfibrozil—Dizziness—Imiquimod—skin cancer	0.00041	0.00205	CcSEcCtD
Gemfibrozil—Vertigo—Temozolomide—skin cancer	0.000409	0.00204	CcSEcCtD
Gemfibrozil—Leukopenia—Temozolomide—skin cancer	0.000407	0.00204	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Dactinomycin—skin cancer	0.000402	0.00201	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000401	0.002	CcSEcCtD
Gemfibrozil—Cough—Temozolomide—skin cancer	0.000397	0.00198	CcSEcCtD
Gemfibrozil—Paraesthesia—Bleomycin—skin cancer	0.000395	0.00198	CcSEcCtD
Gemfibrozil—Vision blurred—Fluorouracil—skin cancer	0.000395	0.00197	CcSEcCtD
Gemfibrozil—Convulsion—Temozolomide—skin cancer	0.000394	0.00197	CcSEcCtD
Gemfibrozil—Vomiting—Imiquimod—skin cancer	0.000394	0.00197	CcSEcCtD
Gemfibrozil—Weight decreased—Docetaxel—skin cancer	0.000393	0.00196	CcSEcCtD
Gemfibrozil—Rash—Imiquimod—skin cancer	0.000391	0.00195	CcSEcCtD
Gemfibrozil—Dermatitis—Imiquimod—skin cancer	0.00039	0.00195	CcSEcCtD
Gemfibrozil—Headache—Imiquimod—skin cancer	0.000388	0.00194	CcSEcCtD
Gemfibrozil—Anaemia—Fluorouracil—skin cancer	0.000387	0.00194	CcSEcCtD
Gemfibrozil—Arthralgia—Temozolomide—skin cancer	0.000387	0.00194	CcSEcCtD
Gemfibrozil—Myalgia—Temozolomide—skin cancer	0.000387	0.00194	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000385	0.00192	CcSEcCtD
Gemfibrozil—Renal failure—Docetaxel—skin cancer	0.00038	0.0019	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Docetaxel—skin cancer	0.000379	0.0019	CcSEcCtD
Gemfibrozil—Jaundice—Docetaxel—skin cancer	0.000377	0.00189	CcSEcCtD
Gemfibrozil—Pain—Bleomycin—skin cancer	0.000376	0.00188	CcSEcCtD
Gemfibrozil—Leukopenia—Fluorouracil—skin cancer	0.000375	0.00188	CcSEcCtD
Gemfibrozil—Confusional state—Temozolomide—skin cancer	0.000374	0.00187	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000374	0.00187	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Temozolomide—skin cancer	0.000371	0.00186	CcSEcCtD
Gemfibrozil—Oedema—Temozolomide—skin cancer	0.000371	0.00186	CcSEcCtD
Gemfibrozil—Nausea—Imiquimod—skin cancer	0.000368	0.00184	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Docetaxel—skin cancer	0.000366	0.00183	CcSEcCtD
Gemfibrozil—Nervous system disorder—Temozolomide—skin cancer	0.000364	0.00182	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Temozolomide—skin cancer	0.000363	0.00182	CcSEcCtD
Gemfibrozil—Convulsion—Fluorouracil—skin cancer	0.000363	0.00182	CcSEcCtD
Gemfibrozil—Feeling abnormal—Bleomycin—skin cancer	0.000363	0.00181	CcSEcCtD
Gemfibrozil—Skin disorder—Temozolomide—skin cancer	0.000361	0.0018	CcSEcCtD
Gemfibrozil—Chest pain—Fluorouracil—skin cancer	0.000357	0.00178	CcSEcCtD
Gemfibrozil—Myalgia—Fluorouracil—skin cancer	0.000357	0.00178	CcSEcCtD
Gemfibrozil—Fatigue—Dactinomycin—skin cancer	0.000354	0.00177	CcSEcCtD
Gemfibrozil—Pain—Dactinomycin—skin cancer	0.000351	0.00175	CcSEcCtD
Gemfibrozil—Urticaria—Bleomycin—skin cancer	0.00035	0.00175	CcSEcCtD
Gemfibrozil—Rhinitis—Docetaxel—skin cancer	0.000348	0.00174	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Docetaxel—skin cancer	0.000346	0.00173	CcSEcCtD
Gemfibrozil—Confusional state—Fluorouracil—skin cancer	0.000345	0.00172	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Fluorouracil—skin cancer	0.000342	0.00171	CcSEcCtD
Gemfibrozil—Oedema—Fluorouracil—skin cancer	0.000342	0.00171	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Docetaxel—skin cancer	0.000341	0.00171	CcSEcCtD
Gemfibrozil—Feeling abnormal—Dactinomycin—skin cancer	0.000338	0.00169	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000338	0.00169	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Dactinomycin—skin cancer	0.000336	0.00168	CcSEcCtD
Gemfibrozil—Nervous system disorder—Fluorouracil—skin cancer	0.000335	0.00168	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Fluorouracil—skin cancer	0.000335	0.00167	CcSEcCtD
Gemfibrozil—Paraesthesia—Temozolomide—skin cancer	0.000333	0.00167	CcSEcCtD
Gemfibrozil—PPARA—connective tissue—skin cancer	0.000332	0.0978	CbGeAlD
Gemfibrozil—Somnolence—Temozolomide—skin cancer	0.00033	0.00165	CcSEcCtD
Gemfibrozil—Dyspepsia—Temozolomide—skin cancer	0.000327	0.00163	CcSEcCtD
Gemfibrozil—Eye disorder—Docetaxel—skin cancer	0.000325	0.00162	CcSEcCtD
Gemfibrozil—Abdominal pain—Dactinomycin—skin cancer	0.000324	0.00162	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Temozolomide—skin cancer	0.00032	0.0016	CcSEcCtD
Gemfibrozil—Fatigue—Temozolomide—skin cancer	0.00032	0.0016	CcSEcCtD
Gemfibrozil—Pain—Temozolomide—skin cancer	0.000317	0.00159	CcSEcCtD
Gemfibrozil—Constipation—Temozolomide—skin cancer	0.000317	0.00159	CcSEcCtD
Gemfibrozil—Asthenia—Bleomycin—skin cancer	0.000316	0.00158	CcSEcCtD
Gemfibrozil—PPARA—epithelium—skin cancer	0.000315	0.0929	CbGeAlD
Gemfibrozil—Mediastinal disorder—Docetaxel—skin cancer	0.000313	0.00157	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000312	0.00156	CcSEcCtD
Gemfibrozil—Pruritus—Bleomycin—skin cancer	0.000311	0.00156	CcSEcCtD
Gemfibrozil—Paraesthesia—Fluorouracil—skin cancer	0.000307	0.00154	CcSEcCtD
Gemfibrozil—Alopecia—Docetaxel—skin cancer	0.000307	0.00154	CcSEcCtD
Gemfibrozil—Feeling abnormal—Temozolomide—skin cancer	0.000306	0.00153	CcSEcCtD
Gemfibrozil—Mental disorder—Docetaxel—skin cancer	0.000304	0.00152	CcSEcCtD
Gemfibrozil—Somnolence—Fluorouracil—skin cancer	0.000304	0.00152	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Temozolomide—skin cancer	0.000304	0.00152	CcSEcCtD
Gemfibrozil—Dyspepsia—Fluorouracil—skin cancer	0.000301	0.00151	CcSEcCtD
Gemfibrozil—PPARA—skin of body—skin cancer	0.0003	0.0883	CbGeAlD
Gemfibrozil—Dysgeusia—Docetaxel—skin cancer	0.000296	0.00148	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000295	0.00148	CcSEcCtD
Gemfibrozil—Urticaria—Temozolomide—skin cancer	0.000295	0.00147	CcSEcCtD
Gemfibrozil—Asthenia—Dactinomycin—skin cancer	0.000294	0.00147	CcSEcCtD
Gemfibrozil—Abdominal pain—Temozolomide—skin cancer	0.000293	0.00147	CcSEcCtD
Gemfibrozil—Pain—Fluorouracil—skin cancer	0.000292	0.00146	CcSEcCtD
Gemfibrozil—Feeling abnormal—Fluorouracil—skin cancer	0.000282	0.00141	CcSEcCtD
Gemfibrozil—Diarrhoea—Dactinomycin—skin cancer	0.000281	0.0014	CcSEcCtD
Gemfibrozil—Vomiting—Bleomycin—skin cancer	0.00028	0.0014	CcSEcCtD
Gemfibrozil—Anaemia—Docetaxel—skin cancer	0.00028	0.0014	CcSEcCtD
Gemfibrozil—Rash—Bleomycin—skin cancer	0.000277	0.00139	CcSEcCtD
Gemfibrozil—Dermatitis—Bleomycin—skin cancer	0.000277	0.00139	CcSEcCtD
Gemfibrozil—Urticaria—Fluorouracil—skin cancer	0.000272	0.00136	CcSEcCtD
Gemfibrozil—Syncope—Docetaxel—skin cancer	0.000271	0.00136	CcSEcCtD
Gemfibrozil—Leukopenia—Docetaxel—skin cancer	0.000271	0.00135	CcSEcCtD
Gemfibrozil—Asthenia—Temozolomide—skin cancer	0.000266	0.00133	CcSEcCtD
Gemfibrozil—Loss of consciousness—Docetaxel—skin cancer	0.000266	0.00133	CcSEcCtD
Gemfibrozil—Cough—Docetaxel—skin cancer	0.000264	0.00132	CcSEcCtD
Gemfibrozil—Pruritus—Temozolomide—skin cancer	0.000263	0.00131	CcSEcCtD
Gemfibrozil—Convulsion—Docetaxel—skin cancer	0.000262	0.00131	CcSEcCtD
Gemfibrozil—Nausea—Bleomycin—skin cancer	0.000261	0.00131	CcSEcCtD
Gemfibrozil—Vomiting—Dactinomycin—skin cancer	0.000261	0.0013	CcSEcCtD
Gemfibrozil—Rash—Dactinomycin—skin cancer	0.000259	0.00129	CcSEcCtD
Gemfibrozil—Chest pain—Docetaxel—skin cancer	0.000258	0.00129	CcSEcCtD
Gemfibrozil—Myalgia—Docetaxel—skin cancer	0.000258	0.00129	CcSEcCtD
Gemfibrozil—Arthralgia—Docetaxel—skin cancer	0.000258	0.00129	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000256	0.00128	CcSEcCtD
Gemfibrozil—Diarrhoea—Temozolomide—skin cancer	0.000254	0.00127	CcSEcCtD
Gemfibrozil—Confusional state—Docetaxel—skin cancer	0.000249	0.00124	CcSEcCtD
Gemfibrozil—Oedema—Docetaxel—skin cancer	0.000247	0.00123	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Docetaxel—skin cancer	0.000247	0.00123	CcSEcCtD
Gemfibrozil—Dizziness—Temozolomide—skin cancer	0.000245	0.00123	CcSEcCtD
Gemfibrozil—Nausea—Dactinomycin—skin cancer	0.000244	0.00122	CcSEcCtD
Gemfibrozil—Shock—Docetaxel—skin cancer	0.000243	0.00121	CcSEcCtD
Gemfibrozil—PPARA—lymphoid tissue—skin cancer	0.000243	0.0715	CbGeAlD
Gemfibrozil—Nervous system disorder—Docetaxel—skin cancer	0.000242	0.00121	CcSEcCtD
Gemfibrozil—Pruritus—Fluorouracil—skin cancer	0.000242	0.00121	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Docetaxel—skin cancer	0.000242	0.00121	CcSEcCtD
Gemfibrozil—Skin disorder—Docetaxel—skin cancer	0.00024	0.0012	CcSEcCtD
Gemfibrozil—Vomiting—Temozolomide—skin cancer	0.000236	0.00118	CcSEcCtD
Gemfibrozil—PPARA—female reproductive system—skin cancer	0.000234	0.069	CbGeAlD
Gemfibrozil—Rash—Temozolomide—skin cancer	0.000234	0.00117	CcSEcCtD
Gemfibrozil—Diarrhoea—Fluorouracil—skin cancer	0.000234	0.00117	CcSEcCtD
Gemfibrozil—Dermatitis—Temozolomide—skin cancer	0.000234	0.00117	CcSEcCtD
Gemfibrozil—Headache—Temozolomide—skin cancer	0.000233	0.00116	CcSEcCtD
Gemfibrozil—Dizziness—Fluorouracil—skin cancer	0.000226	0.00113	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000225	0.00112	CcSEcCtD
Gemfibrozil—Paraesthesia—Docetaxel—skin cancer	0.000222	0.00111	CcSEcCtD
Gemfibrozil—Nausea—Temozolomide—skin cancer	0.000221	0.0011	CcSEcCtD
Gemfibrozil—Somnolence—Docetaxel—skin cancer	0.000219	0.0011	CcSEcCtD
Gemfibrozil—Vomiting—Fluorouracil—skin cancer	0.000217	0.00109	CcSEcCtD
Gemfibrozil—Dyspepsia—Docetaxel—skin cancer	0.000217	0.00109	CcSEcCtD
Gemfibrozil—Rash—Fluorouracil—skin cancer	0.000216	0.00108	CcSEcCtD
Gemfibrozil—Dermatitis—Fluorouracil—skin cancer	0.000215	0.00108	CcSEcCtD
Gemfibrozil—Headache—Fluorouracil—skin cancer	0.000214	0.00107	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Docetaxel—skin cancer	0.000213	0.00107	CcSEcCtD
Gemfibrozil—Fatigue—Docetaxel—skin cancer	0.000213	0.00106	CcSEcCtD
Gemfibrozil—Pain—Docetaxel—skin cancer	0.000211	0.00106	CcSEcCtD
Gemfibrozil—Constipation—Docetaxel—skin cancer	0.000211	0.00106	CcSEcCtD
Gemfibrozil—Feeling abnormal—Docetaxel—skin cancer	0.000203	0.00102	CcSEcCtD
Gemfibrozil—Nausea—Fluorouracil—skin cancer	0.000203	0.00102	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Docetaxel—skin cancer	0.000202	0.00101	CcSEcCtD
Gemfibrozil—PPARA—head—skin cancer	0.000196	0.0576	CbGeAlD
Gemfibrozil—Abdominal pain—Docetaxel—skin cancer	0.000195	0.000976	CcSEcCtD
Gemfibrozil—Asthenia—Docetaxel—skin cancer	0.000177	0.000886	CcSEcCtD
Gemfibrozil—Pruritus—Docetaxel—skin cancer	0.000175	0.000873	CcSEcCtD
Gemfibrozil—Diarrhoea—Docetaxel—skin cancer	0.000169	0.000845	CcSEcCtD
Gemfibrozil—Dizziness—Docetaxel—skin cancer	0.000163	0.000816	CcSEcCtD
Gemfibrozil—CYP1A2—nipple—skin cancer	0.000159	0.0468	CbGeAlD
Gemfibrozil—Vomiting—Docetaxel—skin cancer	0.000157	0.000785	CcSEcCtD
Gemfibrozil—Rash—Docetaxel—skin cancer	0.000156	0.000778	CcSEcCtD
Gemfibrozil—Dermatitis—Docetaxel—skin cancer	0.000156	0.000778	CcSEcCtD
Gemfibrozil—Headache—Docetaxel—skin cancer	0.000155	0.000773	CcSEcCtD
Gemfibrozil—SLCO1B1—female reproductive system—skin cancer	0.000149	0.044	CbGeAlD
Gemfibrozil—Nausea—Docetaxel—skin cancer	0.000147	0.000733	CcSEcCtD
Gemfibrozil—PPARA—lymph node—skin cancer	0.000137	0.0404	CbGeAlD
Gemfibrozil—CYP2C8—female reproductive system—skin cancer	8.49e-05	0.025	CbGeAlD
Gemfibrozil—CYP2C9—female reproductive system—skin cancer	7.54e-05	0.0222	CbGeAlD
Gemfibrozil—CYP3A4—female reproductive system—skin cancer	5.75e-05	0.0169	CbGeAlD
